Publications by authors named "Laura Meijer"

Claim this Profile
P
Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine--paclitaxel in advanced pancreatic cancer.
Lenka N C Boyd, Mahsoem Ali, Jisce R Puik, Annalisa Comandatore, Laura Ginocchi, Laura L Meijer

J Liq Biopsy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations.
Ernesto Rodriguez, Eline S Zwart, Alsya A Affandi, Jan Verhoeff, Mike de Kok, Laura L Meijer

Cancer Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of microRNA-21 in intra- and extrahepatic cholangiocarcinoma after radical resection: cohort study.
Lenka N C Boyd, Mahsoem Ali, Annalisa Comandatore, Giovanni Brandi, Simona Tavolari, Laura L Meijer

BJS Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits, Recruitment, Dropout, and Acceptability of the Strength Back Digital Health Intervention for Patients Undergoing Spinal Surgery: Nonrandomized, Qualitative, and Quantitative Pilot Feasibility Study.
Annemieke van der Horst, Laura Meijer, Harmieke van Os-Medendorp, Jan S Jukema, Ernst Bohlmeijer

JMIR Form Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial immune composition of tumor microenvironment in patients with pancreatic cancer.
Eline S Zwart, Thomas van Ee, Alsya J Affandi, Lenka N C Boyd, Ernesto Rodriguez, Laura L Meijer

Cancer Immunol Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.
Mireia Mato Prado, Jisce R Puik, Leandro Castellano, Elena López-Jiménez, Daniel S K Liu, Laura L Meijer

Exp Hematol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer.
Eline S Zwart, Thomas van Ee, Deesje Doppenberg, Arantza Farina, Johanna W Wilmink, Laura L Meijer

J Cancer Res Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn's disease: preserve or resect the mesentery?
Laura L Meijer, Ninos Ayez, Charlotte S van Kessel

Br J Surg· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.
Lenka N C Boyd, Lynn E Nooijen, Mahsoem Ali, Jisce R Puik, Jasmine Moustaquim, Laura L Meijer

Front Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hENT1 as a Predictive Biomarker in PDAC-Letter.
Lenka N C Boyd, Mahsoem Ali, Jisce R Puik, Laura L Meijer, Tessa Y S Le Large

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.
Lenka N C Boyd, Mahsoem Ali, Annalisa Comandatore, Ingrid Garajova, Laura Kam, Laura L Meijer

JAMA Netw Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and long-term outcomes following pancreatic injury - An international multicenter cohort study.
Laura L Meijer, Yrjö Vaalavuo, Sara Regnér, Ville Sallinen, Aurora Lemma

Heliyon· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors that influence the pancreatic and duodenal microbiome in patients undergoing pancreatic surgery.
Eline S Zwart, Suzanne Jeleniewski, Lenka N C Boyd, Laura L Meijer, Jisce R Puik

PLoS One· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and localization of early- and late-stage cancers using platelet RNA.
Sjors G J G In 't Veld, Mohammad Arkani, Edward Post, Mafalda Antunes-Ferreira, Silvia D'Ambrosi, Anna-Larissa N Niemeijer, Laura L Meijer, Hanne Meijers-Heijboer

Cancer Cell· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits.
Ernesto Rodriguez, Kelly Boelaars, Kari Brown, Katarina Madunić, Thomas van Ee, Laura L Meijer

Commun Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach.
Lenka N C Boyd, Mahsoem Ali, Laura Kam, Jisce R Puik, Stephanie M Fraga Rodrigues, Laura L Meijer

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omics Analysis of Educated Platelets in Cancer and Benign Disease of the Pancreas.
Giulia Mantini, Laura L Meijer, Ilias Glogovitis, Sjors G J G In 't Veld, Rosita Paleckyte

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets.
Tessa Ys Le Large, Giulia Mantini, Laura L Meijer, Thang V Pham, Niccola Funel

JCI Insight· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma.
Laura L Meijer, Ingrid Garajová, Chiara Caparello, Tessa Y S Le Large, Adam E Frampton

Ann Surg· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach.
Tessa Y S Le Large, Laura L Meijer, Rosita Paleckyte, Lenka N C Boyd, Bart Kok

Oncologist· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma.
Laura L Meijer, Marin Strijker, Jacob K de Bakker, Jurgen Gj Toennaer, Barbara M Zonderhuis

World J Gastrointest Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor microbiome: Pancreatic cancer and duodenal fluids contain multitudes, …but do they contradict themselves?
Laura L Meijer, Eline S Zwart, Bernd W Brandt, Reina Mebius, Dongmei Deng

Crit Rev Oncol Hematol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors.
Laura L Meijer, Jisce R Puik, Tessa Y S Le Large, Michal Heger, Frederike Dijk

Cancers (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Current Treatment Options for Duodenal Adenocarcinoma-A Call for Collaborative Studies.
Laura L Meijer, Geert Kazemier

Ann Surg Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine.
Arthur T F Choy, Ilaria Carnevale, Stefano Coppola, Laura L Meijer, Geert Kazemier

Expert Rev Mol Diagn· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis